Football celebrates the athletes who refuse to stop playing. But when a franchise quarterback takes the field with a diagnosed blood clot, the responsibility for protecting him extends well beyond his willingness to compete.
On October 11, Jalen Hurts walked onto the field at Tottenham Hotspur Stadium in London carrying something far more consequential than the Philadelphia Eagles’ hopes for their season. An ultrasound performed the day before had revealed a superficial blood clot in his left calf, and doctors had evaluated the condition and cleared him to play against the Jacksonville Jaguars. Hurts had spent much of the night before at a hospital being evaluated, did not emerge from the tunnel until just before kickoff, and rode a stationary bike between series. He played the entire game. Eight days later, the Eagles and his agent, Nicole Lynn, announced that the 28-year-old quarterback had been diagnosed with deep vein thrombosis and blood clots in both lungs. The player who had been medically cleared to compete is now barred from football activities while he takes blood thinners, and multiple reports say he is expected to miss the rest of the season.
The Eagles say Hurts is clinically stable, his prognosis is very good, and a full recovery is expected. That is encouraging news for an athlete whose career has been defined by discipline, resilience and an extraordinary capacity to perform under pressure. But his situation deserves examination beyond the question of when he might return. It exposes an uncomfortable tension at the center of professional sports: athletes are celebrated for their willingness to endure physical hardship, while the institutions that profit from their performances are also responsible for deciding when the risks have become unacceptable.
The issue is not whether Hurts should have been tougher, more cautious or more willing to challenge the medical advice he received. There is no public evidence that he overruled doctors or that the Eagles knowingly disregarded a medical prohibition. The more consequential question is how an organization evaluates medical risk when everyone surrounding a valuable player has spent years operating inside a culture that treats availability as the defining measure of commitment.
When Toughness Becomes a Professional Obligation
Football has an unusual relationship with pain. The sport requires players to absorb punishment that would send most people home from work, yet returning to the field after an injury is routinely presented as evidence of character. Playing hurt becomes part of an athlete’s reputation, endurance is celebrated as leadership, and the ability to withstand discomfort is treated almost as a professional qualification, especially for quarterbacks expected to set the emotional tone of an entire franchise.
That culture does not require a coach to order an injured player onto the field. Expectations can become powerful without ever being spoken. A player understands what teammates need, what fans expect and what the organization has invested in his availability. Even when medical decisions are formally independent, the broader environment can make stepping away feel like abandoning a responsibility. The pressure is not always imposed by another person. Sometimes it becomes part of how athletes measure their own worth. It’s a version of the same script SSC examined in The ‘Beta Male’ Label Was Built on a Wolf Myth: men learn early that enduring pain quietly is proof of who they are.
Medical ethicists have examined this tension for years. In a 2016 commentary in the Hastings Center Report titled “Being Right Isn’t Always Enough: NFL Culture and Team Physicians’ Conflict of Interest,” Ross McKinney of the Association of American Medical Colleges argued that football’s competitive culture complicates medical decision-making, noting that players want to win and want to help their teams win even when their own health interests are unclear. The piece appeared in a special report on the role of club doctors produced through the Football Players Health Study at Harvard University. It predates Hurts’ situation by a decade, but the underlying conflict has not gone away.
Hurts’ public identity makes the conversation particularly compelling. His career has been shaped by responding to setbacks, staying composed under scrutiny and embracing accountability, and those qualities have made him one of the most recognizable leaders in football. Yet a culture that celebrates perseverance must also recognize its limits. There is a meaningful difference between playing through ordinary discomfort and making decisions about a potentially serious vascular condition. Determination cannot change the biology of a blood clot, and competitive resolve is not a substitute for medical judgment.
The People Paid to Protect the Player
The NFL has formal rules governing medical authority. Under Article 39 of the league’s collective bargaining agreement, the head team physician has final authority over whether a player is medically cleared to participate, and team medical personnel owe their primary duty to the player rather than the club, even though the club pays for their services. Players also retain the right to seek second opinions under specified conditions. On paper, the system recognizes that protecting an athlete’s health must take precedence over the team’s competitive interests.
But the existence of a safeguard does not settle every question about how it operates. Team physicians work inside organizations whose success depends on healthy, available players. Coaches build game plans around those players, and executives make financial commitments based on their performance. Medical professionals must make judgments that can profoundly affect those interests while remaining accountable to the patient. The arrangement does not establish misconduct, but it gives the public a legitimate reason to scrutinize the independence, transparency and consistency of medical decisions.
The Eagles have provided a chronology. According to the team’s October 15 statement, Hurts requested treatment for his calf after practice on October 8, saying he had been cleated during the October 4 loss to the Los Angeles Rams. After the team flew to London, an ultrasound performed out of what the team called an abundance of caution revealed a superficial clot. The team said its medical staff and doctors in London concluded that activity and mobility were important and that Hurts could safely play. A follow-up ultrasound on October 14, after the team returned to Philadelphia, showed movement in the clot, and the Eagles ruled him out of the next game and later placed him on injured reserve.
That account establishes that medical professionals evaluated Hurts before he played. It does not establish that the initial clearance was negligent, nor does it answer every question about the specific clinical findings, the specialists involved or the risk assessment. Physicians not involved in his care have stressed that the case turns on clinical context, including the nature and location of the original clot and how it progressed. It would be irresponsible to conclude from the eventual diagnosis alone that the original decision was medically indefensible. Still, accountability should not depend solely on whether an outcome can be classified as a medical error. A credible system should be able to explain how consequential decisions are made, what safeguards activate when circumstances change, and how independent judgment is preserved when a star player’s availability carries enormous organizational weight.
The Business of Keeping Stars on the Field
The financial structure of professional football makes player availability enormously valuable. Franchise quarterbacks influence ticket demand, television audiences, sponsorships, competitive results and the long-term direction of organizations worth billions of dollars. Their presence shapes the business surrounding the sport, from broadcast programming to merchandise sales to the commercial expectations attached to winning.
None of that proves financial considerations influenced Hurts’ clearance. There is no verified evidence that Eagles executives, coaches or commercial partners pressured medical professionals to approve his participation. But institutional accountability requires examining how organizations manage competing interests, not merely whether an individual can be shown to have acted improperly. When a player’s presence carries substantial economic value, independent medical authority becomes especially important.
There is also a significant imbalance between established stars and players whose jobs are less secure. Hurts has the financial resources, representation and standing of a Super Bowl MVP. A backup fighting for a roster spot or a young player approaching a contract decision has considerably less leverage. Both operate within the same culture of availability, but the personal consequences of missing games can be very different, and a medical system that depends on an athlete’s willingness to push back against organizational expectations may offer uneven protection to the people who need it most.
The NFL already recognizes the value of independent oversight in another area of player safety. Its concussion protocol requires clearance from an independent neurological consultant, a physician not affiliated with any NFL team, before a diagnosed player returns to contact activities. The arrangement shows that the league and the players’ union have built a mechanism for independent review when the consequences of returning too soon warrant it. Blood clots present different medical circumstances, and concussion procedures cannot simply be transplanted onto vascular conditions. Nevertheless, Hurts’ experience raises a legitimate policy question: should certain serious diagnoses require an additional, independently documented review before an athlete participates in a contact sport? The answer should come from medical evidence and an honest look at existing protections rather than public reaction to a single case, but it is a fair question for a league that has already acknowledged the value of independent clearance elsewhere.
Accountability Cannot End With Trust
On October 19, Eagles head coach Nick Sirianni faced repeated questions about the decision to let Hurts play in London and fly back to Philadelphia after his initial diagnosis. Sirianni defended the organization, said player health is always at the forefront of the team’s thinking, and emphasized his confidence in its medical professionals, explaining that he relies on their expertise rather than making clinical judgments himself. When reporters pressed for details about the decision-making, he largely pointed them back to the team’s statements.
There is a reasonable case for a head coach declining to interpret complicated medical findings, particularly when a player’s private health information is involved, and coaches should not substitute their judgment for that of qualified physicians. Yet an organization’s responsibility to explain its safety procedures does not disappear because the underlying decisions were medical. Privacy may limit what can be disclosed about an individual’s condition, but it does not prevent a team from explaining its general protocols, the role of outside specialists or the safeguards governing medical clearance. Saying player health comes first is easy. SSC made the same point about workplaces after World Mental Health Day filled LinkedIn feeds: the measure is what the system does when the statement is over.
The most important unanswered questions concern process. What medical considerations supported the initial clearance? How was the risk of international travel evaluated, both before the game and on the flight home? Which physicians took part in the decision, and what follow-up requirements were set? The Eagles have disclosed parts of that process, including the involvement of doctors in London and the subsequent testing, but the public record does not offer a complete account of each clinical judgment. Asking for greater transparency is not the same as declaring those judgments wrong.
The NFL Players Association’s published guidance on medical rights reinforces that players are entitled to information about their conditions and, under the collective bargaining agreement, access to second opinions. Those protections matter because informed consent requires more than an athlete’s desire to compete. It requires an understanding of the relevant risks and the freedom to decide without improper influence.
The Responsibility to Tell an Athlete to Stop
The culture of toughness extends far beyond football. Across American workplaces, people are praised for working while sick, sacrificing sleep, staying available through personal emergencies and proving commitment through physical or emotional exhaustion. Some employers now say it openly. Venture capitalist Vinod Khosla is recruiting for 12-hour days, nights and weekends, and for many workers the workday ends but the messages don’t. Professional athletes perform a highly visible version of that same expectation, with the added reality that their bodies are the product being sold. It’s the same imbalance SSC traced in Productivity Is Rising. What Are Workers Getting Back?: the people whose effort drives the results rarely control the terms.
Hurts’ circumstances show why the language of perseverance deserves greater scrutiny. His discipline and competitive drive have helped define his career, but they are not reasons to expect him to shoulder responsibility for every medical decision surrounding his participation. The athlete’s obligation is to communicate symptoms, understand the advice he receives and take part in his own care. The institution’s obligation is to maintain safeguards capable of protecting him even when competition, expectations and financial interests all favor his availability.
The immediate priority is Hurts’ recovery. The Eagles and his agent expect him to return to contact football once he is off blood thinners, and the public has no basis to assume otherwise. His eventual return, however, should not determine whether the questions raised by his experience deserve attention. A favorable outcome would not eliminate the need to examine the process, just as an unfavorable one would not automatically establish wrongdoing.
Football has spent generations celebrating athletes who refuse to quit, and the language of sacrifice runs through its broadcasts, locker rooms, advertising and mythology. But there is no conflict between admiring an athlete’s determination and demanding that the institutions around him exercise independent judgment. The true test of a player-safety system is not whether its physicians can clear a star quarterback to compete. It is whether they have the authority, independence and organizational support to keep him off the field when the medical evidence requires it. Jalen Hurts has already demonstrated his toughness, and the responsibility for protecting his health should never rest on how much more of it he is willing to prove.
Sources: Philadelphia Eagles statement (Oct. 15, 2026); joint statement from the Eagles and Nicole Lynn (Oct. 19, 2026); ESPN; ABC News; NewsNation; Billy Penn; Hastings Center Report, Vol. 46, Supplement 2 (2016); NFL–NFLPA Collective Bargaining Agreement, Article 39.